International Journal of Pharmaceutical Chemistry and Analysis
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN:-2394-2789
Online ISSN:-2394-2797
CODEN : IJPCN9
Viewed: 1558
PDF Downloaded: 621
Original Article
Author Details :
Volume : 3, Issue : 1, Year : 2016
Article Page : 13-17
Abstract
A simple, rapid, accurate and economical AUC method has been developed for estimation of Rizatriptan benzoate from bulk and pharmaceutical formulation. The ?max of rizatriptan benzoate in water was found to be 280 nm. The drug follows linearity in the concentration range 6-36 ?g/ml with correlation coefficient value 0.999. The proposed method was applied to pharmaceutical formulation and % amount of drug estimated 98.00% – 102.00% was found in good agreement with the label claim. The accuracy of the method was checked by recovery experiment performed at three different levels i.e., 80%, 100% and 120%. The % recovery was found to be in the range 98.00% – 102.00%. The low values of % RSD are indicative of the accuracy and reproducibility of the method. The precision of the method was studied as an intra-day, inter-day variations and repeatability. The % R.S.D. value less than 2 indicate that the method was precise. Ruggedness of the proposed method was studied with the help of two analysts. The above method was a rapid and cost-effective quality-control tool for routine analysis of Rizatriptan benzoate in bulk and in pharmaceutical dosage form.
Keywords: Area under Curve, Rizatriptan benzoate, Validation
How to cite : Jain P S, Chaudhari H P, Bari P R, Surana S J, Area under Curve Method Development and Validation of Rizatriptan Benzoate. Int J Pharm Chem Anal 2016;3(1):13-17
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.